2-(4-(2,2-dimethylbutyl)-2-(4-(pyridin-2-yl)phenethyl)-1H-imidazol-1-yl)acetic acid

ID: ALA4518142

Chembl Id: CHEMBL4518142

PubChem CID: 155541223

Max Phase: Preclinical

Molecular Formula: C24H29N3O2

Molecular Weight: 391.52

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(C)(C)Cc1cn(CC(=O)O)c(CCc2ccc(-c3ccccn3)cc2)n1

Standard InChI:  InChI=1S/C24H29N3O2/c1-4-24(2,3)15-20-16-27(17-23(28)29)22(26-20)13-10-18-8-11-19(12-9-18)21-7-5-6-14-25-21/h5-9,11-12,14,16H,4,10,13,15,17H2,1-3H3,(H,28,29)

Standard InChI Key:  TWQYVPPQCFDMDQ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4518142

    ---

Associated Targets(Human)

BRS3 Tchem Bombesin receptor subtype-3 (700 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Brs3 Bombesin receptor subtype-3 (412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 391.52Molecular Weight (Monoisotopic): 391.2260AlogP: 4.79#Rotatable Bonds: 9
Polar Surface Area: 68.01Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.11CX Basic pKa: 6.99CX LogP: 3.33CX LogD: 2.84
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.57Np Likeness Score: -0.71

References

1. Kiyotsuka Y, Shimada K, Kobayashi S, Suzuki M, Akiu M, Asano M, Sogawa Y, Hara T, Konishi M, Abe-Ohya R, Izumi M, Nagai Y, Yoshida K, Abe Y, Takamori H, Takahashi H..  (2016)  Synthesis and biological evaluation of novel imidazol-1-ylacetic acid derivatives as non-brain penetrant bombesin receptor subtype-3 (BRS-3) agonists.,  26  (17): [PMID:27491709] [10.1016/j.bmcl.2016.07.056]

Source